DIALYSIS · CCN 282511

DaVita Omaha South Dialysis

OMAHA, NE 68107

DialysisProfitDaVita
$4.7M
TOTAL REVENUE
31.1%
OPERATING MARGIN
3 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.7M
Total costs
$3.2M
Operating income (rev − costs)
$1.5M
Operating margin
31.1%
Total charges
$4.5M
Total treatments
10,744
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.1634—
Fistula Rate
DFC_FISTULA_RATE
57.893—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.9339—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
150.873—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.18——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1593—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
21.1291—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
8.277—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
37.765—
Standardized ED Visits Ratio
DFC_SEDR
0.9325—